Navigation Links
Labopharm Reports Results for Third Quarter Fiscal 2007
Date:11/9/2007

------------------------------------------------------------------------

444 563 1,646 1,211

-------------------------------------------------------------------------

-------------------------------------------------------------------------

NET LOSS FOR THE PERIOD (9,031) (4,361) (26,539) (16,700)

-------------------------------------------------------------------------

-------------------------------------------------------------------------

NET LOSS PER SHARE -

BASIC AND DILUTED (0.16) (0.08) (0.47) (0.33)

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Weighted average number

of common shares

outstanding 56,817,963 56,747,093 56,795,545 50,938,493

-------------------------------------------------------------------------

-------------------------------------------------------------------------

INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

For the: Three months ended Nine months ended

Sept 30, Sept 30, Sept 30, Sept 30,

2007 2006 2007 2006

(Thousands of Canadian

dollars) $ $ $ $

-------------------------------------------------------------------------

OPERATING ACTIVITIES

Net loss for the period (9,031) (4,361) (26,539) (16,700)

Items not affecting cash:

Depreciation of property,

plant and equipment 448 375 1,304 1,105

Amortization of intangible

assets 62 55 178 171

Amortizatio
'/>"/>

SOURCE Labopharm Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy
2. Labopharm provides update on U.S. regulatory process for once-daily Tramadol
3. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
4. Labopharm appeals FDAs decision on once-daily tramadol
5. Labopharm to host conference call Friday, November 9, 2007 at 8:30 a.m. (ET)
6. Labopharm to present at CIBC World Markets 18th Annual Healthcare Conference
7. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
8. Haemacure Reports Third Quarter 2007 Results
9. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
10. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
11. MDS Reports Third Quarter 2007 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... Vintners and guests, generosity will fund much-n... Hillsboro, OR (PRWEB) November 25, 2009 -- I...oir Auction topped $607,700 in proceeds over the...Spurred by the Big Board auction of special 2008 P...000 above 2008 totals, over 400 guests bid enthusi...
(Date:11/25/2009).../PRNewswire/-- AdamDreamHealer,s GlobalIntentionHe...sthephysiologyofsomeoneatadistance.Over10,000parti...teerwhowasmonitoredbyaquantitative-EEG.Thedatawasa...vember8inVancouver,B.C.Adaminitiatedtheworld,slarg...Adamcreatedavideoclipofaspecificvisualizationtobeu...
(Date:11/24/2009)...versity of Miami School of Medicine compared the o...transplants for nonalcoholic steatohepatitis (NASH...no statistically significant differences in post-t... groups. Study findings are presented in the Decem...blished by Wiley-Blackwell on behalf of the Americ...
(Date:11/24/2009)...RNewswire/--Theholidayseasoncanbeatimefullofjoy,ch...peciallythoserecoveringfromaneatingdisorder,it,sat...iluresandanxietyaboutanuncertainfuture.Familygathe...nbechallengingandsometimesawkward. ,, "Inmyprac...ereatingwiththefamily and duringtheholidayscanofte...
(Date:11/24/2009)...24/PRNewswire/--HealthPlusofMichiganhaslaunchedfou...cificallyforindividuals18to64andtheirfamilieswhoar.... ,, Thenew HealthPlusSignature plansareavailab...brokersthroughouttheHealthPlusservicearea.Moreinfo...ebytoll-freephonecallto1-877-562-0907. ,, "Wear...
Breaking Medicine News(10 mins):Health News:Salud! The Oregon Pinot Noir Auction Raises Over $607,000 2Health News:Salud! The Oregon Pinot Noir Auction Raises Over $607,000 3Health News:Intriguing Scientific Results from World's Largest Intention Healing Project: DreamHealer 2Health News:New data emerges on liver transplant survival rates 2Health News:New data emerges on liver transplant survival rates 3Health News:When Holiday Meals Aren't a Gift 2Health News:HealthPlus Offers New Insurance Plans for Consumers Seeking Health Coverage on Their Own 2
...ungunya, a relatively rare form of mosquito-transm...istrict of Madhya Pradesh, and the disease has spr...re deaths Sunday - two from remote Dunava and one ... said Thursday. 'The dead include a 10-year-...
...nt research in California has revealed that DDT ca...ers were exposed to the pesticide//. While DDT ...s in Africa plan to expand its use to combat mosqu...f California, Berkeley, the potential benefits of ...
...th services at the All India Institute of Medical ...culty members continued their strike to protest th...l services, including the OPD and emergency, were ...adoss recommended the removal of Venugopal for vio...
...omen who are at risk for infertility and needing c...ar maturation in vitro when immature follicles wer... a group of researchers at the Northwestern Univer...d helped maintain a normal connection between foll...
...e loss of a protein named menin – involved in tumo...nction resulted in the proliferation of pancreatic...egulation - researchers at the University of Penns...(MEN1) and this discovery also has implications fo...
...dian scientists claim to have discovered a safe an...sprouts//. Prof. Keith Warriner and his coll... a sanitizer to kill pathogens such as salmonella ...llet is that it can selectively kill the bacteria ...
Other Medicine News:Health News:Chikungunya Death Toll Raises to 12 in Madhya Pradesh 2Health News:Developmental Delays in Infants Linked to DDT 2Health News:A three-dimensional Culture System ensures Female Fertility 2Health News:Menin Gene Mutation made Insulin Secreting Cells to Proliferate 2Health News:Sanitizer For Contaminated Sprouts Developed 2
(Date:11/24/2009)...wire/--AFOXThanksgivingDaytelevisionspecialcalled"...iewersthattheholidaysareatimetobegratefulformanyde...ofightthatbattleeachdayassurvivors,caregivers,anda...eturntotheiceofcancersurvivorsScottHamiltonandDoro...avidFosterwhowillperform"HopeisAlwaysHere,"asongwr...
(Date:11/24/2009)...PRNewswire-FirstCall/--BioSpecificsTechnologiesCor...ingfirstinclasscollagenase-basedproducts,todayanno...entattheupcomingPiperJaffray21stAnnualHealthCareCo...wYorkPalaceHotelinNewYork,NY. ,, Alivewebcastof..."intheInvestorRelationssectionoftheCompany,swebsit...
(Date:11/23/2009)...wire/--TwooftheChicagoarea,sleadingBoardCertifiedD...sbreastimaging,couplingthelatesttechnologyindigita...htheabilitytohavethefullrangeofdigitalimagingcompl...eavestheoffice.Drs.AhmedFaragandJoanWerberaredeliv...t6-9monthwaitforanappointmentcommonlyfoundinChicag...
Breaking Medicine Technology:FOX Thanksgiving Day Special 'Kaleidoscope' Unites Cancer Survivors on Ice and in Song to Celebrate Survivorship 2FOX Thanksgiving Day Special 'Kaleidoscope' Unites Cancer Survivors on Ice and in Song to Celebrate Survivorship 3Axium Healthcare Pharmacy Inc Has Been Chosen as One of Central Floridas Golden 100 Companies for the Fifth Year in a Row 56618 1Axium Healthcare Pharmacy Inc Has Been Chosen as One of Central Floridas Golden 100 Companies for the Fifth Year in a Row 56618 2Red Cross Sees Increase in Youth Volunteers During United We Serve Program 56615 1Red Cross Sees Increase in Youth Volunteers During United We Serve Program 56615 2Red Cross Sees Increase in Youth Volunteers During United We Serve Program 56615 3U of I scientist 3A Public policy should promote family mealtimes 9845 1U of I scientist 3A Public policy should promote family mealtimes 9845 2U of I scientist 3A Public policy should promote family mealtimes 9845 3
...Data Presented on Valopicitabine Combined,with an ...in, April 12, 2007 /PRNewswire-FirstCall/ --,Ideni...om two phase,IIb studies of the novel combination ... alfa-2a (Pegasys(R)) in both treatment-naive,and ...genotype-1,strain of the hepatitis C virus (HCV). ...
...alif., April 11, 2007 (PRIME NEWSWIRE) --,Hana Bio...y focused,on advancing cancer care, will present p...Injection at the American Association,for Cancer R...Los,Angeles, California. , Abstract No. 2210: "Com... non-small cell lung cancer (NSCLC) athymic nude,m...
Other Medicine Technology:Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 2Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 3Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 4Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 5Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 6Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 7Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting 2Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting 3
...horse for the lab, featuring easy-to-use control k...e. , Product features , , Digital display w...(W x D) footprint fits on a crowded bench, or in a...otor provides maintenance-free operation , Spin...
...z, 100/120 V Fast - Powerful g-Force for Fast an... up to 14,000 rpm (18,000 x g) Ideal for pelletin... Fits on crowded bench or in a cold room Comes...ble fixed-angle rotor Quiet operation ≤ 58 ...
...f laboratory floor model centrifuge meets UL and C... is suitable for use in Class 1, Group D hazardous... gasoline, petroleum, naphtha, benzol, lacquer, so... specifications is so strict that the EXD design a...
Avanti J-30I
Medicine Products: